NNH — New Nordic Healthbrands AB Income Statement
0.000.00%
- SEK117.71m
- SEK148.89m
- SEK533.85m
- 73
- 47
- 27
- 44
Annual income statement for New Nordic Healthbrands AB, fiscal year end - December 31st, SEK millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | SAS | SAS | SAS | SAS | SAS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 453 | 450 | 515 | 488 | 534 |
Cost of Revenue | |||||
Gross Profit | 316 | 309 | 350 | 319 | 348 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 416 | 426 | 486 | 492 | 537 |
Operating Profit | 36.3 | 23.8 | 28.5 | -4.75 | -3.17 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 36.1 | 23.3 | 28 | -5.17 | -5.92 |
Provision for Income Taxes | |||||
Net Income After Taxes | 28.1 | 17.8 | 21.3 | -2.82 | -6.2 |
Net Income Before Extraordinary Items | |||||
Net Income | 28.1 | 17.8 | 21.3 | -2.82 | -6.2 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 28.1 | 17.8 | 21.3 | -2.82 | -6.19 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 4.53 | 2.87 | 3.44 | -0.456 | -1 |
Dividends per Share |